173 related articles for article (PubMed ID: 16111527)
41. Skin metastases revealing a bilateral ovarian invasive micropapillary serous carcinoma.
Moussa A; Denguezli W; Njim L; Haddad A; Faleh R; Sakouhi M; Zakhama A
Arch Gynecol Obstet; 2008 Jul; 278(1):71-4. PubMed ID: 18066568
[TBL] [Abstract][Full Text] [Related]
42. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
[TBL] [Abstract][Full Text] [Related]
43. Is micropapillary serous carcinoma for real?
Gershenson DM
Cancer; 2002 Aug; 95(4):677-80. PubMed ID: 12209709
[No Abstract] [Full Text] [Related]
44. Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
Alobaid A; Bruchim I; Verkooijen H; Gauthier P; Petignat P
Eur J Surg Oncol; 2006 Apr; 32(3):358-62. PubMed ID: 16414233
[TBL] [Abstract][Full Text] [Related]
45. Bilateral micropapillary serous carcinoma of the ovary: a case report.
Gupta R; Singh S; Nigam S
Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
[TBL] [Abstract][Full Text] [Related]
46. [Uterine papillary serous carcinoma: report of a case].
Dai L; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):557-8. PubMed ID: 20021972
[No Abstract] [Full Text] [Related]
47. Role of surgical staging and adjuvant treatment in uterine serous carcinoma.
Frey MK; Bashir S; Ward NM; Hensel KJ; Caputo TA; Holcomb KM; Baergen R; Gupta D
Eur J Gynaecol Oncol; 2013; 34(5):453-6. PubMed ID: 24475582
[TBL] [Abstract][Full Text] [Related]
48. [Proliferating serous papillary cystadenoma of the borderline type in myometrium of the fundus uteri].
Grouls V
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):559-62. PubMed ID: 9036071
[TBL] [Abstract][Full Text] [Related]
49. Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma.
Lai CR; Yen MS; Wang PH
Taiwan J Obstet Gynecol; 2014 Jun; 53(2):139-40. PubMed ID: 25017255
[No Abstract] [Full Text] [Related]
50. Four primary malignancies successively occurred in a BRCA2 mutation carrier: a case report.
Fruscalzo A; Damante G; Calcagno A; Di Loreto C; Marchesoni D
Cancer Invest; 2006 Oct; 24(6):611-4. PubMed ID: 16982466
[TBL] [Abstract][Full Text] [Related]
51. Early stage uterine serous carcinoma: management updates and genomic advances.
Fader AN; Santin AD; Gehrig PA
Gynecol Oncol; 2013 Apr; 129(1):244-50. PubMed ID: 23321062
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
[TBL] [Abstract][Full Text] [Related]
53. Julian CG, Woodruff JD. The biologic behavior of low-grade papillary serous carcinoma of the ovary. Obstet Gynecol 1972; 40:860-7.
Pitkin RM
Obstet Gynecol; 2003 Sep; 102(3):452. PubMed ID: 12962923
[No Abstract] [Full Text] [Related]
54. [Treatment results in endometrial cancer in patients of reproductive age].
Vishnevskaia EE
Vopr Onkol; 2006; 52(4):451-4. PubMed ID: 17024821
[TBL] [Abstract][Full Text] [Related]
55. Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case.
Canbay E; Ishibashi H; Sako S; Kitai T; Nishino E; Hirano M; Mizumoto A; Endo Y; Ogura S; Yonemura Y
Surg Today; 2014 Feb; 44(2):373-7. PubMed ID: 23435809
[TBL] [Abstract][Full Text] [Related]
56. [Mitotic activity in serous adenocarcinoma of the uterine body].
Vasil'eva EV; Belianin VL
Vopr Onkol; 2005; 51(2):206-10. PubMed ID: 16223002
[TBL] [Abstract][Full Text] [Related]
57. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
Trahan S; Têtu B; Raymond PE
Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
[TBL] [Abstract][Full Text] [Related]
58. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma.
Sagr ER; Denschlag D; Kerim-Dikeni A; Stanimir G; Gitsch G; Gilbert L
Anticancer Res; 2007; 27(2):1213-7. PubMed ID: 17465265
[TBL] [Abstract][Full Text] [Related]
60. Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.
Amant F; Vergote I
Gynecol Oncol; 2004 Apr; 93(1):272-3; author reply 273-4. PubMed ID: 15047252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
